Xponance Inc. decreased its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 21.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 64,450 shares of the company's stock after selling 18,008 shares during the period. Xponance Inc.'s holdings in Cardinal Health were worth $7,623,000 as of its most recent filing with the SEC.
Other hedge funds have also recently modified their holdings of the company. Promus Capital LLC bought a new position in Cardinal Health during the fourth quarter valued at about $30,000. Kentucky Trust Co bought a new position in shares of Cardinal Health during the 4th quarter valued at approximately $41,000. HHM Wealth Advisors LLC increased its stake in shares of Cardinal Health by 57.6% during the 4th quarter. HHM Wealth Advisors LLC now owns 394 shares of the company's stock worth $47,000 after purchasing an additional 144 shares during the last quarter. Raleigh Capital Management Inc. raised its holdings in shares of Cardinal Health by 29.6% in the 4th quarter. Raleigh Capital Management Inc. now owns 464 shares of the company's stock worth $55,000 after purchasing an additional 106 shares during the period. Finally, Quarry LP lifted its stake in Cardinal Health by 541.7% in the third quarter. Quarry LP now owns 616 shares of the company's stock valued at $68,000 after purchasing an additional 520 shares during the last quarter. Institutional investors own 87.17% of the company's stock.
Analysts Set New Price Targets
Several brokerages have issued reports on CAH. Morgan Stanley boosted their target price on Cardinal Health from $136.00 to $142.00 and gave the company an "overweight" rating in a research note on Friday, January 31st. Citigroup upped their price objective on shares of Cardinal Health from $120.00 to $129.00 and gave the company a "neutral" rating in a report on Friday, January 10th. Mizuho assumed coverage on shares of Cardinal Health in a research report on Wednesday, December 4th. They issued an "outperform" rating and a $139.00 price target on the stock. Jefferies Financial Group raised shares of Cardinal Health from a "hold" rating to a "buy" rating and raised their price objective for the stock from $140.00 to $150.00 in a report on Wednesday, February 5th. Finally, TD Cowen raised shares of Cardinal Health from a "hold" rating to a "buy" rating and boosted their target price for the company from $130.00 to $144.00 in a report on Wednesday, January 8th. Four investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $139.36.
Check Out Our Latest Stock Report on Cardinal Health
Cardinal Health Price Performance
NYSE CAH traded up $1.36 during trading on Monday, reaching $133.25. The company's stock had a trading volume of 2,153,232 shares, compared to its average volume of 1,975,725. The stock has a market capitalization of $32.19 billion, a PE ratio of 24.86, a P/E/G ratio of 1.49 and a beta of 0.66. The firm has a fifty day moving average of $127.35 and a 200 day moving average of $120.08. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $133.67.
Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.
Cardinal Health Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be issued a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.52%. The ex-dividend date is Tuesday, April 1st. Cardinal Health's payout ratio is currently 37.69%.
Cardinal Health Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
See Also
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
